- Home
- ODC vs KURA Comparison
ODC vs KURA Comparison
Compare ODC & KURA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ODC | KURA |
|---|---|---|
| Founded | 1941 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Miscellaneous manufacturing industries | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.1B |
| IPO Year | 1994 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ODC | KURA |
|---|---|---|
| Price | $89.42 | $13.03 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $25.56 |
| AVG Volume (30 Days) | 110.8K | ★ 2.2M |
| Earning Date | 06-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.13% | N/A |
| EPS Growth | ★ 50.45 | N/A |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $485,572,000.00 | $67,482,000.00 |
| Revenue This Year | N/A | $28.28 |
| Revenue Next Year | N/A | $106.37 |
| P/E Ratio | $53.64 | ★ N/A |
| Revenue Growth | 10.97 | ★ 25.24 |
| 52 Week Low | $45.61 | $7.36 |
| 52 Week High | $107.00 | $13.90 |
Technical Indicators
Market Signals| Indicator | ODC | KURA |
|---|---|---|
| Relative Strength Index (RSI) | 42.75 | 64.67 |
| Support Level | $85.61 | $7.96 |
| Resistance Level | $95.07 | $13.90 |
| Average True Range (ATR) | 2.94 | 0.68 |
| MACD | 0.09 | 0.09 |
| Stochastic Oscillator | 26.24 | 73.57 |
Price Performance
Historical ComparisonAbout ODC Oil-Dri Corporation Of America
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.
About KURA Kura Oncology Inc.
Kura Oncology Inc is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for the treatment of cancer. The company develops small-molecule medicines designed to target cancer signaling pathways in oncology and hematology. Its pipeline includes menin inhibitor ziftomenib for the treatment of acute myeloid leukemia and other hematologic malignancies, as well as additional product candidates such as KO-7246 and darolifarnib being evaluated for solid tumors and other diseases.